WuXi Biologics
Offering End-to-End Solutions
- About Us
About Us - Services & SolutionsAbout Us
- Investor RelationsAbout Us
- News & ResourcesAbout Us
Services & Solutions
Information Downloads
WuXi XDC: The Bioconjugation Leader
From Target to Market - Comprehensive Services for ADCs/Bioconjugates
| WuXi XDC is a dedicated CRDMO providing end-to-end discovery, development, and manufacturing services for bioconjugates and antibody drug conjugates (ADCs). Our one-stop comprehensive technology platform greatly simplifies Antibody Drug Conjugate (ADC) and other bioconjugate drug development by providing lead screening and selection, preclinical activities, holistic and integrated CMC development, and the entire production supply chain, with one company and in one centralized region. |
Discuss This Service Overview
To discuss the information in this service overview, please complete the form on the following page to connect with our experts.
Notice:
You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?